HilleVax, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
HilleVax, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q3 2024.
  • HilleVax, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$25.8M, a 18.8% increase year-over-year.
  • HilleVax, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$150M, a 39.4% decline year-over-year.
  • HilleVax, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$124M, a 22.7% increase from 2022.
  • HilleVax, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$160M, a 56.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$150M -$25.8M +$5.99M +18.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$156M -$40.7M -$12.8M -45.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$144M -$46.8M -$19.9M -74.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$124M -$37M -$15.8M -74.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$108M -$31.8M -$15M -89.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$92.8M -$27.9M +$26M +48.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$119M -$26.9M +$41M +60.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$160M -$21.2M +$16.1M +43.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$176M -$16.8M +$45.1M +72.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$221M -$53.9M -$52.3M -3135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$169M -$67.9M -$66.3M -4291% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$102M -$37.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$61.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1.67M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$1.55M Jan 1, 2021 Mar 31, 2021 10-Q 2022-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.